Akers Biosciences Inc (AKR)

 

Latest News

US Distribution Agreement: Cholesterol Self-test

RNS Number: 6905Q Akers Biosciences, Inc. 01 December 2016 1 December 2016 This announcement contains inside information Akers Biosciences, Inc. US Distribution Agreement for Rapid Cholesterol Self-test Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (the "Company" or "Akers Bio"), a developer of rapid health information technologies, has signed a ...

Akers Bio completes BreathScan DKA trial

Akers Biosciences has completed a clinical trial for BreathScan DKA, the first single-use, non-invasive breath test to rapidly...

Clinical Trial for BreathScan DKA Completed

RNS Number: 2656Q Akers Biosciences, Inc. 28 November 2016 28 November 2016 This announcement contains inside information Akers Biosciences, Inc. Clinical Trial for Diabetic Ketoacidosis Breath Test Completed Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), ( " Akers Bio " or the "Company"), a developer of rapid health information technologies, has...

Notice of AGM

RNS Number: 0360P Akers Biosciences, Inc. 14 November 2016 Akers Biosciences, Inc. Notice of Annual General Meeting Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (the "Company" or "Akers Bio"), a developer of rapid health information technologies, announces that a notice convening an Annual General Meeting ("AGM") of the Company will be ava...

All News

DateHeadlineSource
01-12-16US Distribution Agreement: Cholesterol Self-testRNS
28-11-16Akers Bio completes BreathScan DKA trial StockMarketWire
28-11-16Clinical Trial for BreathScan DKA CompletedRNS
14-11-16Notice of AGMRNS
14-11-16Akers Bio revenues up 262%StockMarketWire
14-11-16Akers Bio revenues up 262%StockMarketWire
14-11-163rd Quarter ResultsRNS
10-11-16Akers Bio schedules Q3 results StockMarketWire
10-11-16Akers Bio granted European patentStockMarketWire
10-11-16European Patent GrantedRNS
09-11-16Notice of Q3 ResultsRNS
25-10-16Filing of Form S-3 Registration StatementRNS
19-08-16Akers Bio settles dispute with ChubeWorkxStockMarketWire
19-08-16Settlement of Dispute with ChubeWorkxRNS
18-08-16Akers Bio excited about OxiChek results StockMarketWire
18-08-16Results of OxiChek Test StudyRNS
11-08-16Akers Bio gross profits up 34%StockMarketWire
11-08-16Half Yearly ResultsRNS
09-08-16Notice of H1 2016 EarningsRNS
30-06-16Akers Bio completes clinical trial for Chlamydia testStockMarketWire
30-06-16Clinical Trial for Rapid Chlamydia Test CompletedRNS
27-06-16Akers distribution deal for OxiChekStockMarketWire
27-06-16Distribution Agreement for BreathScan OxiChekTRNS
17-06-16Broker Forecast - finnCap issues a broker note on Akers Biosciences IncStockMarketWire
14-06-16Issue of Equity & PDMR ShareholdingRNS
26-05-16PDMR ShareholdingRNS
12-05-16Akers Bio product revenue up 79%StockMarketWire
12-05-16Financial Results for Q1 2016RNS
10-05-16Akers Bio schedules Q1 resultsStockMarketWire
10-05-16Notice of Q1 ResultsRNS
25-04-16Board changes at Akers BiosciencesStockMarketWire
25-04-16Board RearrangementRNS
30-03-16Akers Bio's lossStockMarketWire
30-03-16Final ResultsRNS
23-03-16Akers Bio gets US patent StockMarketWire
23-03-16US Patent - Heparin/PF4 Antibody DetectionRNS
16-03-16Akers Bio schedules FY results StockMarketWire
16-03-16Notice of ResultsRNS
02-03-16Akers Bio wins USD2.5m product order StockMarketWire
02-03-16$2.5M Product OrderRNS

RSS feeds

  • Editorial news feed for LSE:AKR Editorial
  • Regulatory news feed for LSE:AKR Regulatory